This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (2446)
-
March 26, 2026 | Insight Novo Nordisk targets Indian drugmaker Dr Reddy's over formulation, trademark claims
...Property heads asserting that their formulation does not infringe the patent....
Sections: Intellectual Property
-
March 25, 2026 | Insight US 'ceding leadership' to China, EU when it comes to IP, InterDigital VP warns
...“Only with the powers resulting from the exclusive right can the intellectual property — in this case...
Sections: Intellectual Property
-
March 25, 2026 | Insight US judge 'reluctantly' allows new infringement claim in authors' AI case
Sections: Artificial Intelligence and Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login